Indian Institute of Science venom drug startup raises $2.7m
Tech in Asiaen
Venomics AI uses molecular sequencing, AI, and lab testing to identify venom-derived molecules that could be developed into drug candidates.
This is a short summary published by AI Global Wire. The full article is owned and hosted by Tech in Asia — open it there to read it in full.
Read the full story at Tech in Asia- Företag
Related AI news
- Agent Harness Awareness: Turning Verified Telemetry into Operational Control for Tool-Using AgentsarXiv cs.AI · November 5, 2026
- AGORA: Reliability-Aware Aggregation of LLM Judges via Item-Response TheoryarXiv cs.AI · November 5, 2026
- Can Large Language Models Review the Scientific Literature? A Test Against a 102-Article BenchmarkarXiv cs.AI · November 5, 2026
- AI chip startup Tenspresso seeks $50m at $500m valuationTech in Asia · November 5, 2026
- Sources: China has told SoftBank it will not allow the $5.4B acquisition of ABB's robotics division to go ahead; China is the division's biggest market (David Keohane/Financial Times)Techmeme · November 5, 2026
- China's Big Fund III pivots to 12-inch chip fabs, equipment acquisitions to close semiconductor supply chain gapsDIGITIMES · November 5, 2026